What You Should Know:
- Joi Women’s Wellness (Joi), a modern, femtech proactive approach to women’s health care, today announced the company’s official nationwide launch and availability of its hormone optimization and peptide therapy treatments, as well as the introduction of a new telehealth platform that provides a goals-based, customizable experience to help women own their health journey and manage the hormone and age–related changes to their bodies.
- Joi offers health coaching and
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
How Healthcare Organizations Can Enhance Patient Experience & Trust During the Winter Surge
It’s well known that the winter season typically creates spikes in illness and, consequently, a surge in healthcare visits. What might not be so obvious is that this time of increased demand is also the ideal opportunity for healthcare organizations to prioritize building trust and improving experiences for patients, clinicians and team members.
Just as science grows more sophisticated each year, allowing practitioners to better treat a greater number of medical ailments, so should
Read More
FemTech: Samsung Adds Menstrual Cycle Tracking Capabilities to Galaxy Watch5
What You Should Know:
- Samsung Galaxy Watch5 users will soon be able to access temperature-based menstrual cycle tracking through the Cycle Tracking feature. This new capability was developed in partnership with Natural Cycles, a women’s health company and app maker, and marks the first time Natural Cycles’ algorithm has been adapted for a smartwatch.
- The partnership combines Natural Cycles’ fertility technology with Samsung’s BioActive Sensor to give users more detailed
Read More
The Quickening Pulse of the Ambulatory Diagnostic Cardiology Market
The Global Ambulatory Diagnostic Cardiology Market is evolving at a rapid pace, driven by technological developments, and shifting models of healthcare service delivery and funding. The overall market will grow from $2.5 billion in 2021, to $3.3 billion by 2026, with Long-Term ECG and, to a lesser extent, Mobile Cardiac Telemetry (MCT), being the principal engines of growth. Unsurprisingly, these two markets are garnering serious attention from large incumbent vendors in the more established
Read More
Unintended Bias in AI-Driven Healthcare Applications
What You Should Know:
- Over the past few years, Artificial Intelligence (AI), and more specifically, Machine Learning (ML) technology, have experienced rapid adoption in the healthcare space as tools for diagnosis and decision-making. Such tools are intended to address challenges in the healthcare system to both processes and put into practice the proliferating medical findings, and also to support delivery of the promise of personalized and precision medicine.
- Unintended bias in AI and
Read More
BenchSci Launches ‘Map’ of Biology Research Platform for Pharmaceutical Research
What You Should Know:
- BenchSci, a Canadian-based tech company and leader in AI solutions for drug discovery recently launches a Google-backed 'map' of biology research platform, ASCEND™ by BenchSci, to understand the underlying biology.
- The patented machine learning platform reads millions of published and previously hidden experiment external and internal data sources to create a map that allows scientists to more quickly (50% more) and accurately understand the biological
Read More
Luna to Deliver In-Home Physical Therapy for AARP Members
What You Should Know:
- Luna, a provider of in-home physical therapy, announced that it has been chosen as the exclusive provider of in-home physical therapy for AARP members.
- Based on specialty, geography, schedule, and other factors, Luna will match AARP members with local therapists at the time and location of their choosing. For consistency of care, the same therapist will treat AARP members for the entirety of the treatment plan. Additionally, AARP members and therapists
Read More
Vida Health Expands its Cardiometabolic Capabilities
What You Should Know:
- Vida Health is expanding its solution for chronic conditions by adding the ability to prescribe and deprescribe glucagon-like peptide 1 (GLP-1) agonists for both type 2 diabetes and obesity for appropriate patients. As part of Vida’s value-oriented treatments for cardiometabolic conditions, patients with obesity and diabetes will now be candidates for GLP-1 therapy within the Vida platform.
- With the addition of GLP-1s and other obesity medications in higher acuity
Read More
Veradigm and HealthVerity Partner to Advance Real-World Evidence for Cardiovascular Disease and Diabetes
What You Should Know:
- Today, Veradigm and HealthVerity announced a collaboration to advance research and improve patient care for those with cardiovascular disease and diabetes. The collaboration makes Veradigm’s data from their Cardiovascular and Metabolic Registries fully interoperable with de-identified patient data from HealthVerity Marketplace, the nation’s largest healthcare and consumer data ecosystem.
- The HealthVerity IPGE platform is an integrated technology and
Read More
Wellstar Expands Enterprise Virtual Reality Training with Moth+Flame
What You Should Know:
- Wellstar Health System extends its partnership with Moth+Flame to further utilize its virtual reality (VR) training technology.
- The VR emotional intelligence training encourages Wellstar's employees to build composure and gain practical experience in a highly realistic scenario by navigating difficult conversations and testing resiliency in an emotionally charged environment.
- The experience helps Wellstar's workforce development
Read More
